Science.bio Closed: What Happened and the Safe Alternative (2026)
On January 27, 2026, Science.bio permanently closed. Its founders chose to shut down voluntarily and committed to fulfilling outstanding orders or issuing full refunds first. Even a vendor that exits responsibly still leaves you with no source and no prescriber. Here is the path that does not vanish.
If you are looking for a Science.bio alternative, here is why: on January 27, 2026, Science.bio permanently closed. Unlike the grey-market vendors that shut down abruptly and strand their customers, its founders chose to close voluntarily after reading the regulatory environment, and Science.bio committed to fulfilling all outstanding orders or providing full refunds before it went dark. That was a responsible exit. It also changed nothing about the core problem: once the site closed, there was no prescriber, no licensed pharmacy, and no ongoing source.
This guide lays out the verified facts of what happened, why a grey-market vendor with no prescriber and no licensed pharmacy is fragile even when it behaves well on the way out, and the safe way forward: a prescribed, pharmacy-grade path where a licensed physician prescribes, an FDA-registered 503A pharmacy compounds, a Certificate of Analysis verifies each batch, and pru prices the peptide at cost. pru is built only for that path and it does not vanish.
Science.bio closed on January 27, 2026, and here is the safe alternative
Science.bio, a research-peptide vendor, permanently closed on January 27, 2026. Its founders chose to shut down voluntarily after reading the regulatory environment, and the company committed to fulfilling all outstanding orders or providing full refunds before closing. That responsible exit is the exception among grey-market shutdowns, and it still left customers with no prescriber, no licensed pharmacy, and no ongoing source.
The safe alternative is not another grey-market site selling vials labeled for research use only. It is a prescribed, pharmacy-grade path: the same kinds of peptides, but ordered through a licensed telehealth provider where a physician confirms the peptide is appropriate for you and a 503A pharmacy fills it with a Certificate of Analysis. That is the difference between a research chemical that can close its doors and a medicine you can stand behind.
THE ONE LINE THAT MATTERSScience.bio did right by its customers on the way out and still disappeared. A vendor with no prescriber and no licensed pharmacy is fragile by design. A prescribed, pharmacy-grade path is not. pru only does that path.
What happened to Science.bio
The verified facts are narrow. On January 27, 2026, Science.bio permanently closed. Unlike the grey-market vendors that shut down abruptly and leave customers stranded, its founders chose to close voluntarily after reading the regulatory environment. Before closing, Science.bio committed to fulfilling all outstanding orders or providing full refunds, so customers who had money in flight were made whole rather than stranded. That distinguishes this closure from a sudden disappearance, and it is worth stating plainly.
The company framed the decision as a read of where the sector was heading. The record cites a set of converging pressures on the research-chemical market as the drivers behind the closure.
- FDA enforcement escalation. Rising regulatory pressure on grey-market peptide sellers.
- Payment-processing restrictions. Tightening access to the payment rails that grey-market vendors depend on.
- Litigation. Legal exposure weighing on the sector.
- The proposed SAFE Drugs Act. Legislation that would bar selling research chemicals identical to FDA-approved drugs without a New Drug Application, read as a direct threat to the model.
WHAT IS CONFIRMEDConfirmed: Science.bio permanently closed on January 27, 2026 as a voluntary decision by its founders, and committed to fulfilling all outstanding orders or issuing full refunds before shutting down. The drivers cited for the decision are FDA enforcement escalation, payment-processing restrictions, litigation, and the proposed SAFE Drugs Act.
The customer impact is the part that matters most if you are reading this. Even with orders fulfilled or refunded, buyers were left with no prescriber to call, no licensed pharmacy on the hook, and no ongoing source. A responsible exit closed the immediate money question. It did not give anyone a durable place to get their peptide next month.
Why this happens to grey-market vendors
A closure like this is not a freak event, and Science.bio is not an outlier for having closed. It is an outlier for having closed gracefully. The built-in risk of the grey-market model is that a research-chemical vendor sells vials labeled for laboratory research only, which is how it stays outside the rules that apply to anything meant to go into a person.
That same structure is what lets it close its doors at will. When there is no prescriber, no licensed pharmacy, and no regulated party standing behind the product, there is also no one obligated to keep serving you, whatever the vendor chooses to do on its final day.
- No prescriber. No licensed clinician reviewed your history or is responsible for your care, so no one is obligated to keep it going.
- No licensed pharmacy. No 503A or 503B facility, no pharmacist oversight, and no dispensing record tied to you.
- No accountability for the product. A seller-attested Certificate of Analysis is only as durable as the seller, and third-party testing has flagged quality problems across the sector.
- No continuity when it ends. Even a refund does not give you a transferable prescription or an ongoing source. When the site goes dark, your supply chain goes with it.
THE LESSONScience.bio fulfilled or refunded every order and still left its customers with no source and no prescriber. The peptides may be real, but the vendor is fragile by design. When the whole sector is under pressure, the responsible exits and the abrupt ones both end the same way for you.
Science.bio was not the only vendor to close in this window. The wider wave of grey-market shutdowns is worth understanding, and so is the two-tier distinction underneath it. See the 2026 peptide vendor shutdowns, pharmacy-grade vs grey-market peptides, and research-grade vs pharmacy-grade peptides.
The safe pharmacy-grade alternative
The safe alternative is pharmacy-grade. A licensed physician prescribes, an FDA-registered 503A pharmacy compounds the peptide for you as an individual, a Certificate of Analysis verifies each batch, and, with pru, the peptide is priced at cost. Every part that a grey-market vendor skips is added back, and every part that lets a grey-market vendor close its doors on you is replaced with an accountable, regulated one. Here is the contrast, line by line.
| What matters | A grey-market vendor | pru (pharmacy-grade) |
|---|---|---|
| Can it end your access overnight? | Yes; a vendor with no prescriber or licensed pharmacy can close at will, as Science.bio did on January 27, 2026, even after fulfilling or refunding orders | No; pru is an accountable, LegitScript-certified telehealth and pharmacy path |
| Prescriber | None; no clinician at any step | Licensed U.S. physician confirms the peptide is appropriate for you, or advises against it |
| Who fills it | Research-chemical supplier; no pharmacy in the chain | FDA-registered 503A compounding pharmacy |
| Testing | Seller-attested at best; third-party testing has flagged quality problems in the sector | A Certificate of Analysis verifies every batch |
| Continuity | None; a refund is not a source, and there is no prescriber or pharmacy to continue with | A licensed provider and pharmacy stand behind every fill and continue your care |
| Pricing | Per-vial retail, paid up front | Peptides at cost, itemized, plus a separate $50/mo membership (billed annually) |
The trade is clear. A grey-market vendor gives you a vial and a disclaimer, and it can be gone tomorrow, refund or not. pru gives you a prescriber, a licensed pharmacy, a batch-verified fill, and at-cost pricing you can read line by line, from a provider that stays accountable and continues your care.
When you start on a 3-month plan, pru's compounded semaglutide comes to about $60 a month and tirzepatide to about $93 a month, because the medication is priced at cost with no markup. Membership is separate: $50 a month billed annually for unlimited at-cost access, so the savings compound with every vial and you can stack more than one peptide without a markup on any of them. To vet any provider yourself, see how to verify a peptide source and where to buy peptides safely online.
How pru works, at cost
pru is a LegitScript-certified DTC membership telehealth platform built only for compounded peptides. pru's content guides you to the peptide that fits your goal and you choose it, a licensed physician confirms it is appropriate for you (or advises against it) and sets the dose, an FDA-registered 503A pharmacy compounds and fills it with a Certificate of Analysis, and the peptide is priced at cost, itemized, with no markup on the medicine.
When you start on a 3-month plan, your price for compounded semaglutide comes to about $60 a month (about $93 a month for tirzepatide), the lowest, because the medication is at cost.
Membership is separate: $50 a month billed annually for unlimited access to the platform and clinician messaging, so the savings compound with every vial and you can stack more than one peptide without a markup on any of them. pru offers compounded peptides, including semaglutide, tirzepatide, NAD+, glutathione, sermorelin, GHK-Cu cream, PT-141 nasal spray, and oxytocin, as injection, nasal spray, or GHK-Cu cream. pru does not sell research-grade material, SARMs, testosterone, or hCG.
Browse everything available now in the full catalog, or see the at-cost pricing. If you were buying for weight care, the weight loss & metabolism category has the GLP-1 options; for NAD+ and longevity, see cellular health.
Losing a supplier is a prompt worth acting on, even when that supplier did right by you on the way out. It is the moment to be proactive about your health and move onto a prescribed, tested path that stays accountable to you and continues your care. Take the next step whenever you are ready.
WHERE PRU SITSpru works only in the prescribed, pharmacy-grade tier: individualized, 503A-compounded peptides documented with a Certificate of Analysis. Pharmacy-grade means a physician prescribed it and a licensed pharmacy made it. It does not mean FDA-approved.
Related reading
- The 2026 Peptide Vendor Shutdowns
- Pharmacy-Grade vs Grey-Market Peptides
- Research-Grade Peptide Alternatives
- How to Verify a Peptide Source
- Where to Buy Peptides Safely Online
- How to Start Peptide Therapy
Common questions
Sources & further reading
- Science.bio closure notice, January 27, 2026 (permanent, voluntary closure chosen by founders after reading the regulatory environment; commitment to fulfill all outstanding orders or provide full refunds before shutting down). Accessed July 2026.
- Reporting on the Science.bio closure and the drivers cited for the decision: FDA enforcement escalation, payment-processing restrictions, litigation, and the proposed SAFE Drugs Act (which would bar selling research chemicals identical to FDA-approved drugs without a New Drug Application). Accessed July 2026.
- U.S. Food and Drug Administration. Human Drug Compounding and Compounding and the FDA: Questions and Answers (503A; compounded drugs are not FDA-approved). fda.gov. Accessed July 2026.
- pru catalog, category, and pricing pages. joinpru.com. Accessed July 2026.
- Compounded peptide pricing (internal pru research): pru compounded semaglutide medication approx. $60/mo and tirzepatide approx. $93/mo on a 3-month starter plan, priced at cost, with a separate $50/mo membership (billed annually, unlimited at-cost access). Accessed July 2026.
- LegitScript. Healthcare Merchant Certification. legitscript.com. Accessed July 2026.